Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.78
Delayed Data
As of 4:00pm ET
 +0.01 / +0.56%
Today’s Change
0.99
Today|||52-Week Range
2.71
-19.46%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.77
Today’s open1.79
Day’s range1.70 - 1.80
Volume655,409
Average volume (3 months)605,858
Market cap$243.1M
Dividend yield--
Data as of 4:00pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+5.00%
Earnings growth (this year)-33.33%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-1.43%
P/E ratioNM
Price/Sales13.70
Price/Book14.49

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.42-5.85%
SELBSelecta Biosciences ...-0.32-2.32%
ITEKInotek Pharmaceutica...+0.25+2.78%
KPTIKaryopharm Therapeut...+0.10+1.42%
Data as of 4:00pm ET, 07/25/2016

Financials

Next reporting dateAugust 1, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.1M
Annual profit (last year)-$22.7M
Net profit margin-118.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts

Partner Offers

Search for Jobs